AI-based methods present enormous potential to revolutionise the diagnosis and management of PCOD by providing accurate, interpretable, and personalised care, and development of clinically interpretable models.
A. Wal, Mekala Moorthy, Rakesh Verma et al.· Current pharmaceutical desig...· 0 citations
Multimodal strategies integrating RMT, stimuli-responsive carriers, and CRISPRbased gene delivery may collectively overcome the translational gap that single-platform approaches have consistently failed to bridge.
Manish R. Bhise, K. Thejomoorthy, Mohit Kumar et al.· Current Drug Delivery· 0 citations
The Alzheimer's Disease (AD) lacks effective disease-modifying therapy, even though amyloid-targeting immunotherapies have recently been applied clinically. N-methyl-D-Aspartate Receptors (NMDARs) play a central yet mechanistically complicated role in the pathophysiology of AD, where they are convergence points of amyl...
Md Sirajuddin Khan, A. M. Ashesh, Mithul V. Mammen et al.· Current Neuropharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.